Analysis of the TCGA and GTEx datasets revealed that DUOX2 expression was significantly higher in pancreatic cancer tissues than in normal tissues, and its elevated expression correlated with shorter overall patient survival, showing that DUOX2 is a potential oncogenic driver (Figure 4H,I). Here, DUOX2 is linked to familial pancreatic carcinoma.